Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Non-enteric coated pancreatic enzymes are a porcine-derived biologic therapy being investigated by the Asian Institute of Gastroenterology for the management of pain in patients with chronic pancreatitis. Unlike standard enteric-coated preparations designed for malabsorption, this formulation is intended to release high doses of proteases (specifically 30,000 units) in the duodenum. The mechanism involves the negative feedback inhibition of cholecystokinin (CCK) receptors, which reduces pancreatic stimulation and intraductal pressure, thereby alleviating pain. This approach is being evaluated in the NE-PERT (Non-enteric Coated Enzymes for Pain in Chronic Pancreatitis) clinical trial (NCT05042284).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on non-enteric coated pancreatic enzymes.